4.8 Review

Glaucoma

Journal

LANCET
Volume 390, Issue 10108, Pages 2183-2193

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(17)31469-1

Keywords

-

Funding

  1. Alcon
  2. Allergan
  3. Roche
  4. Santen
  5. Tomey
  6. Carl Zeiss Meditec
  7. Ellex
  8. Ocular Therapeutics
  9. Quark
  10. Thea
  11. Horus
  12. Sensimed AG
  13. iSonic Medical
  14. Aeon Astron Europe
  15. Santen Pharmaceutical
  16. Ocular Instruments
  17. Gerson Lehrman Group
  18. Gillis Zago Professional
  19. Donahey Defossez Beausay
  20. Nauts
  21. Tanoury
  22. McKinney Garbarino
  23. Diopsys
  24. GLIA
  25. Guardion Health Sciences
  26. Mobius Therapeutics
  27. Intelon Optics
  28. Xoma
  29. International Eye Wellness Institute

Ask authors/readers for more resources

Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intraocular pressure is lowered by 30-50% from baseline. Its worldwide age-standardised prevalence in the population aged 40 years or older is about 3.5%. Chronic forms of glaucoma are painless and symptomatic visual-field defects occur late. Early detection by ophthalmological examination is mandatory. Risk factors for primary open-angle glaucomathe most common form of glaucoma-include older age, elevated intraocular pressure, sub-Saharan African ethnic origin, positive family history, and high myopia. Older age, hyperopia, and east Asian ethnic origin are the main risk factors for primary angle-closure glaucoma. Glaucoma is diagnosed using ophthalmoscopy, tonometry, and perimetry. Treatment to lower intraocular pressure is based on topical drugs, laser therapy, and surgical intervention if other therapeutic modalities fail to prevent progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available